BC
Balachandra Chadaga
About Balachandra Chadaga
Data last updated:
Balachandra Chadaga is a Director at Novotech Clinical Research India Private Limited (since 2021). The company operates in Pharma. Novotech Clinical Research India Private Limited reported revenue of ₹44.62 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novotech Clinical Research India Private Limited U85110KA2007PTC169840 | Director | 30 Nov 2021 | 2007 | ₹44.62 Cr (FY 2023) | Active |
Board colleagues of Balachandra Chadaga
| Name | DIN | Company | Designation |
|---|---|---|---|
| John Russell Moller | 07827551 | Novotech Clinical Research India Private Limited | Director |
| Veronica Therese Holloway | 09652864 | Novotech Clinical Research India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Balachandra Chadaga
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Balachandra Chadaga
Balachandra Chadaga currently holds 1 directorship: Novotech Clinical Research India Private Limited (Director, since 30 Nov 2021, revenue ₹44.62 Cr (FY 2023)).
Balachandra Chadaga was first appointed on 30 Nov 2021 as Director at Novotech Clinical Research India Private Limited.
The current boards of Balachandra Chadaga's companies include John Russell Moller (Novotech Clinical Research India Private Limited), Veronica Therese Holloway (Novotech Clinical Research India Private Limited).